Pathological response and safety of two neoadjuvant strategies with bevacizumab in MRI-defined locally advanced T3 resectable rectal cancer: a randomized, noncomparative phase II study
- Resource Type
- Article
- Source
- In
Annals of Oncology November 2014 25(11):2205-2210 - Subject
- Language
- ISSN
- 0923-7534